CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 160 enrolled
Drug / intervention
EyeControl-Pro +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06029244
NCT06029244N/ACompleted
CompareCT.gov

Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE) : A Multicenter Randomized Controlled Trial

Beth Israel Deaconess Medical Center·interventional·Posted Sep 8, 2023·Updated Dec 3, 2025

In Brief

A clinical study evaluating EyeControl-Pro and Control for Delirium and 3 related conditions. Completed, enrolled 160 participants across 3 sites in 2 countries.

Detailed Summary

The purpose of this research is to investigate whether addition of the EyeControl-Pro platform as an adjunct to standard guideline-based intensive care unit management of critically ill patients is effective in reducing delirium incidence and severity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDelirium, Delirium in Old Age, Critical Illness, Intensive Care Unit Delirium
CountriesIsrael, United States
CollaboratorsBIRD (Israel-United States Binational Industrial Research and Development) Foundation- Funding agency, Rabin Medical Center, Assuta Medical Center, Eyefree Assisting Communication Ltd

Timeline

N/ACompletedFinished
202420252026
First PostedSep 8, 2023
Enrollment StartFeb 25, 2024
Primary CompletionOct 20, 2025
Study CompletionNov 18, 2025
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 2.8 years ago

Interventions

EyeControl-Prodevice

Based on artificial intelligence (AI)-powered eye-tracking technology, the EyeControl-Pro wearable device and smart platform enable 24/7 customizable communication and monitoring between ventilated patients who cannot speak, their families, and medical teams

Controlother

No intervention